Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease

Circulation Journal

Volumn 77, Issue 12, 2013, Pages 3037-3044

  Igarashi, Gen ^a   Iino, Kenji ^a   Watanabe, Hiroyuki ^a   Ito, Hiroshi ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast induced acute kidney injury; Coronary angiography; Liver type fatty acid binding protein; Remote ischemic preconditioning

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; FATTY ACID BINDING PROTEIN; IOPAMIDOL; N (G), N (G) DIMETHYLARGININE; PENTRAXIN 3; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC PRECONDITIONING; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC PRECONDITIONING; RENAL PROTECTION;

ACUTE KIDNEY INJURY; AGED; ANGIOGRAPHY; C-REACTIVE PROTEIN; CONTRAST MEDIA; FATTY ACID-BINDING PROTEINS; HUMANS; ISCHEMIC PRECONDITIONING; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SERUM AMYLOID P-COMPONENT; TIME FACTORS;

EID: 84888220192     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0171     Document Type: Article

References (53)

1. Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J 2008; 72: 1499-1505.
2. Naruse H, Ishii J, Hashimoto T, Kawai T, Hattori K, Okumura M, et al. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing emergency coronary inter-vention. Circ J 2012; 76: 1848-1855.
3. Brezis M, Rosen S. Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 1995; 332: 647-655.
4. Dauerman HL. In search of an algorithm to prevent acute kidney injury. JACC Cardiovasc Interv 2009; 2: 1125-1127.
5. Heyman SN, Goldfarb M, Carmeli F, Shina A, Rahmilewitz D, Brezis M. Effect of radiocontrast agents on intrarenal nitric oxide (NO) and NO synthase activity. Exp Nephrol 1998; 6: 557-562.
6. Nozue T, Michishita I, Iwaki T, Mizuguchi I, Miura M. Contrast medium volume to estimated glomerular fltration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol 2009; 54: 214-220.
7. Bartorelli AL, Marenzi G. Contrast-induced nephropathy. J Interv Cardiol 2008; 21: 74-85.
8. Mockel M, Radovic M, Kuhnle Y, Combe V, Waigand J, Schroder S, et al. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 2008; 23: 1588-1594.
9. Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, et al. Renal Insuffciency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury. Circulation 2011; 124: 1260-1269.
10. Shoukat S, Gowani SA, Jafferani A, Dhakam SH. Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract 2010; 2010: 649164.
11. Waikar SS, Bonventre JV. Creatinine kinetics and the defnition of acute kidney injury. J Am Soc Nephrol 2009; 20: 672-679.
12. Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006; 47: 439-444.
13. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 2004; 143: 23-30.
14. Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka T. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest 2012; 42: 557-563.
15. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: First clinical application in humans. J Am Coll Cardiol 2006; 47: 2277-2282.
16. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, et al. Effect of remote ischaemic preconditioning on myo-cardial injury in patients undergoing coronary artery bypass graft surgery: A randomised controlled trial. Lancet 2007; 370: 575-579.
17. Kharbanda RK, Li J, Konstantinov IE, Cheung MM, White PA, Frndova H, et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: A preclinical study. Heart 2006; 92: 1506-1511.
18. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002; 106: 2881-2883.
19. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: A randomized controlled trial. Circulation 2007; 116 (Suppl): I98-I105.
20. Venugopal V, Laing CM, Ludman A, Yellon DM, Hausenloy D. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: A secondary analysis of 2 small randomized trials. Am J Kidney Dis 2010; 56: 1043-1049.
21. Walsh SR, Boyle JR, Tang TY, Sadat U, Cooper DG, Lapsley M, et al. Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: A randomized controlled trial. J Endovasc Ther 2009; 16: 680-689.
22. Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: Randomized pilot RenPro Trial (Renal Protection Trial). Circulation 2012; 126: 296-303.
23. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.
24. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial. J Lab Clin Med 2005; 145: 125-133.
25. Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim TH, et al. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury: A systematic review and meta-analysis. Circ J 2012; 76: 2255-2265.
26. Saluja I, Song D, O'Regan MH, Phillis JW. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett 1997; 233: 97-100.
27. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, et al. Urinary excretion of fatty acid-binding protein refects stress overload on the proximal tubules. Am J Pathol 2004; 165: 1243-1255.
28. Nagatomo F, Fujino H, Kondo H, Ishihara A. Oxygen concentration-dependent oxidative stress levels in rats. Oxid Med Cell Longev 2012; 2012: 381763.
29. Trotti R, Carratelli M, Barbieri M. Performance and clinical application of a new, fast method for the detection of hydroperoxides in serum. Panminerva Med 2002; 44: 37-40.
30. Trotti R, Carratelli M, Barbieri M, Micieli G, Bosone D, Rondanelli M, et al. Oxidative stress and a thrombophilic condition in alcoholics without severe liver disease. Haematologica 2001; 86: 85-91.
31. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: Role of dimethylarginine dimethylaminohydro-lase. Circ Res 2003; 92: 226-233.
32. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, et al. Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 2005; 16: 2456-2461.
33. Ribichini F, Gambaro G, Graziani MS, Pighi M, Pesarini G, Pasoli P, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem 2012; 58: 458-464.
34. Stacul F, Adam A, Becker CR, Davidson C, Lameire N, McCullough PA, et al. Strategies to reduce the risk of contrast-induced nephropa-thy. Am J Cardiol 2006; 98: 59K-77K.
35. Abe M, Kimura T, Morimoto T, Furukawa Y, Kita T. Incidence of and risk factors for contrast-induced nephropathy after cardiac catheter-ization in Japanese patients. Circ J 2009; 73: 1518-1522.
36. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta 2006; 374: 1-7.
37. Matsui K, Kamijo-Ikemori A, Sugaya T, Yasuda T, Kimura K. Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults. Circ J 2012; 76: 213-220.
38. Tepel M, Zidek W. N-Acetylcysteine in nephrology; contrast nephrop-athy and beyond. Curr Opin Nephrol Hypertens 2004; 13: 649-654.
39. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: A novel protective method from ischemia reperfusion injury - a review. J Surg Res 2008; 150: 304-330.
40. Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, et al. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 2012; 26: 87-93.
41. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/ Akt-dependent activation of Nrf2. Circ Res 2007; 101: 723-733.
42. Saxena P, Newman MA, Shehatha JS, Redington AN, Konstantinov IE. Remote ischemic conditioning: Evolution of the concept, mechanisms, and clinical application. J Cardiac Surg 2010; 25: 127-134.
43. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94: 1069-1075.
44. Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P, Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632-642.
45. Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: Protective role of L-arginine. Kidney Int 1998; 53: 1736-1742.
46. Ueda S, Yamagishi S, Kaida Y, Okuda S. Asymmetric dimethylargi-nine may be a missing link between cardiovascular disease and chronic kidney disease. Nephrology (Carlton) 2007; 12: 582-590.
47. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylamino-hydrolase. Circulation 2002; 106: 987-992.
48. Andreucci M, Lucisano G, Faga T, Bertucci B, Tamburrini O, Pisani A, et al. Differential activation of signaling pathways involved in cell death, survival and infammation by radiocontrast media in human renal proximal tubular cells. Toxicol Sci 2011; 119: 408-416.
49. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, et al. The remote ischemic preconditioning stimulus modifes infammatory gene expression in humans. Physiol Genom-ics 2004; 19: 143-150.
50. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, Kolocassides KG, Adamopoulos S, Karavolias G, et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? Heart 2006; 92: 1821-1826.
51. Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci 2009; 54: 221-224.
52. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac cath-eterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail 2009; 31: 910-919.
53. Waring WS, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clin Toxicol 2011; 49: 720-728.